A detailed history of Harvest Fund Management Co., LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 2,569 shares of BMY stock, worth $151,237. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,569
Holding current value
$151,237
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $101,886 - $132,945
2,569 New
2,569 $132,000
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $382,037 - $433,317
-5,814 Reduced 80.93%
1,370 $95,000
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $244,405 - $289,410
3,569 Added 98.73%
7,184 $517,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $234 - $138,312
1,800 Added 99.17%
3,615 $257,000
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $97,338 - $113,473
1,815 New
1,815 $113,000
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $21,916 - $23,866
-354 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $87,348 - $98,241
-1,472 Reduced 80.61%
354 $22,000
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $31,757 - $35,986
-550 Reduced 23.15%
1,826 $113,000
Q3 2020

Nov 04, 2020

SELL
$57.43 - $63.64 $274,113 - $303,753
-4,773 Reduced 66.76%
2,376 $140,000
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $320,422 - $374,606
-5,845 Reduced 44.98%
7,149 $424,000
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $123,609 - $179,633
2,664 Added 25.79%
12,994 $723,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $282,662 - $368,707
5,744 Added 125.25%
10,330 $820,000
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $196,143 - $232,556
4,586 New
4,586 $233,000
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $158,912 - $189,483
-3,522 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$55.19 - $62.25 $194,379 - $219,244
3,522 New
3,522 $219,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.